Sanofi’s New CEO Inherits a Sparse Cupboard and Tough Turnaround

(Bloomberg Opinion) -- In his four years as chief executive officer of Sanofi, the French pharma giant, Olivier Brandicourt has been unable to convince investors that he can overcome the company’s ...